BEGIN:VCALENDAR VERSION:2.0 PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN X-WR-TIMEZONE:Europe/London METHOD:PUBLISH BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20260519T160000 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:CiviCRM_EventID_1980_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com SUMMARY:Webinar - Balancing Funding of Research with Fundi ng of Development: Impact on Future UK R&D Employm ent X-ALT-DESC;FMTTYPE=text/html:

Continu ing the series of webinar discussing developments in the UK Biopharma sector\, their impact on emplo yment opportunities and potential solutions to cre ate growth in the future. 

\n \n

The webinar will look at the balance of investment between di scovery research and clinical development support in the UK\, be that from government\, charity or p rivate capital pools. As private investors have tr ended towards later stage opportunities and TechBi o approaches have impacted drug discovery strategi es lab-based scientific roles have been compromise d. Whether incentivising clinical development in t he UK will secure greater retention of discovery r esearch or whether continued discovery research fu nding will anchor the clinical development pipelin e in the UK as companies scale-up will be discusse d along with the potential impact on the employmen t\, required skills and how individuals can move w ith demand.

\n \n

*Agenda:
\n 16.00 – W elcome\, Tony Jones\, One Nucleus 
\n 16.05 – Who is funding what at the current time?
\n David Montgomery\, PM Life Sciences Consulting
\n 16.10 – Why funding drug discovery research i n the UK matters
\n Matthew Fyfe\, Outrun The rapeutics
\n 16.15 – Why fixing the clinical development environment in the UK matters
\n Sheuli Porkess\, PM Life Sciences Consulting
\n 16.20 – Open Q&A
\n 16.50 – Aligning skill s with an evolving drug discovery and development industry
\n Natasha Robbins\, BioTc Search
\n 17.00 – Close 
\n *Subject to change.\n  
\n Registration:
\n Fre e for all to attend but pre-registration essential .

DESCRIPTION:Continuing the series of webinar discussing develo pments in the UK Biopharma sector\, their impact o n employment opportunities and potential solutions to create growth in the future. \n \n \n \n The w ebinar will look at the balance of investment betw een discovery research and clinical development su pport in the UK\, be that from government\, charit y or private capital pools. As private investors h ave trended towards later stage opportunities and TechBio approaches have impacted drug discovery st rategies lab-based scientific roles have been comp romised. Whether incentivising clinical developmen t in the UK will secure greater retention of disco very research or whether continued discovery resea rch funding will anchor the clinical development p ipeline in the UK as companies scale-up will be di scussed along with the potential impact on the emp loyment\, required skills and how individuals can move with demand.\n \n \n \n *Agenda:\n \n 16.00 – Welcome\, Tony Jones\, One Nucleus \n \n 16.05 – Who is funding what at the current time?\n \n Davi d Montgomery\, PM Life Sciences Consulting\n \n 16 .10 – Why funding drug discovery research in the U K matters\n \n Matthew Fyfe\, Outrun Therapeutics\ n \n 16.15 – Why fixing the clinical development e nvironment in the UK matters\n \n Sheuli Porkess\, PM Life Sciences Consulting\n \n 16.20 – Open Q&A \n \n 16.50 – Aligning skills with an evolving dru g discovery and development industry\n \n Natasha Robbins\, BioTc Search\n \n 17.00 – Close \n \n *S ubject to change.\n \n  \n \n Registration:\n \n F ree for all to attend but pre-registration essenti al.\n \n CATEGORIES:Events CALSCALE:GREGORIAN DTSTAMP;TZID=Europe/London:20260519T160000 DTSTART;TZID=Europe/London:20260519T160000 DTEND;TZID=Europe/London:20260519T170000 LOCATION:ONLINE - webinar details will be sent to all deleg ates closer to the date of the event\n Cambridge\, \n United Kingdom\n URL:https://onenucleus.com/civicrm/event/info?reset=1&id=1980 END:VEVENT END:VCALENDAR